Securities code: 002107 securities abbreviation: Shandong Wohua Pharmaceutical Co.Ltd(002107) Announcement No.: 2022-014 Shandong Wohua Pharmaceutical Co.Ltd(002107)
Announcement on the election of employee representative supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The term of office of the sixth board of supervisors of the company is about to expire. In order to ensure the normal operation of the board of supervisors of the company, according to the relevant provisions of the company law and the articles of association, the company held the employee congress of the company in the conference room of the company on January 18, 2022. After deliberation by the participants, the following resolutions were adopted:
According to the relevant provisions of the company law, the articles of association and the rules of procedure of the board of supervisors, it is unanimously agreed to elect Mr. Zhou Wanhui and Ms. Liu Lijuan as the employee representative supervisors of the seventh board of supervisors of the company. The seventh board of supervisors of the company will be formed together with three non employee representative supervisors elected by the general meeting of shareholders of the company, and the term of office of the seventh board of supervisors will expire. The above employee representative supervisors meet the qualifications and conditions of supervisors in the company law, the articles of association and other laws and regulations. None of the employee representative supervisors elected by the employee congress of the company has served as a director or senior manager of the company in the past two years. See the attachment for resume.
It is hereby announced.
January 19, 2002
Attachment: resume of Employee Representative Supervisor
Zhou Wanhui, Chinese nationality, without permanent overseas residency, male, born in January 1974, graduated from Shenyang Pharmaceutical University, majoring in traditional Chinese medicine and pharmacy, with a bachelor’s degree. Since joining Weifang traditional Chinese medicine factory (the predecessor of the company) in August 1998, he has successively served as the R & D Manager and deputy director of R & D department. He is currently the vice president of the Institute of traditional Chinese medicine of the company, the director of R & D Department of Liaoning wohua Kangchen Pharmaceutical Co., Ltd. and the director of R & D Department of Nanchang Jishun Pharmaceutical Co., Ltd. He is currently the supervisor of the company.
Zhou Wanhui, who holds 9500 shares of the company, has no relationship with shareholders, actual controllers, other directors, supervisors and senior managers holding more than 5% of the company’s shares. Have not been punished by the CSRC and other relevant departments or disciplined by the stock exchange; It has not been filed for investigation by judicial organs for suspected crimes or checked by CSRC for suspected violations of laws and regulations, and there is no clear conclusion; There is no one who has been publicized by the CSRC on the public inquiry platform of illegal and dishonest information in the securities and futures market or included in the list of dishonest Executees by the people’s court; There are no circumstances specified in article 3.2.2 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, which meets the employment conditions specified in the company law and the articles of association.
Liu Lijuan, Chinese nationality, without permanent overseas residency, female, born in June 1984, graduated from Shandong University of traditional Chinese medicine with a bachelor’s degree. He has successively served as the deputy director of the personnel administration center of Beijing CSI Wanrong pharmaceutical Investment Group Co., Ltd. He joined the company in September 2007 and successively served as the training supervisor of the staff service department of the marketing center and the manager of the personnel administration center. He is currently the supervisor of the company, the deputy director of the personnel administration center and the director of the human resources department of the office of the board of directors.
Ms. Liu Lijuan, who does not hold the company’s shares, has no relationship with the shareholders, actual controllers, other directors, supervisors and senior managers who hold more than 5% of the company’s shares. Have not been punished by the CSRC and other relevant departments or disciplined by the stock exchange; It has not been filed for investigation by judicial organs for suspected crimes or checked by CSRC for suspected violations of laws and regulations, and there is no clear conclusion; There is no one who has been publicized by the CSRC on the public inquiry platform of illegal and dishonest information in the securities and futures market or included in the list of dishonest Executees by the people’s court; There are no circumstances specified in article 3.2.2 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, which meets the employment conditions specified in the company law and the articles of association.
